Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.
Identifieur interne : 000F28 ( PubMed/Curation ); précédent : 000F27; suivant : 000F29Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.
Auteurs : Balazs I. Bodai [États-Unis] ; Phillip TusoSource :
- The Permanente journal [ 1552-5775 ] ; 2015.
Descripteurs français
- KwdFr :
- Effets secondaires indésirables des médicaments (), Femelle, Humains, Lymphoedème (étiologie), Lésions radio-induites (), Mode de vie, Observance thérapeutique, Ostéoporose (), Qualité de vie, Résultat thérapeutique, Seconde tumeur primitive (), Survie sans rechute, Thromboembolie (), Tumeurs du sein ().
- MESH :
English descriptors
- KwdEn :
- Breast Neoplasms (complications), Breast Neoplasms (therapy), Disease-Free Survival, Drug-Related Side Effects and Adverse Reactions (complications), Female, Humans, Life Style, Lymphedema (etiology), Neoplasms, Second Primary (complications), Osteoporosis (chemically induced), Patient Compliance, Quality of Life, Radiation Injuries (complications), Thromboembolism (complications), Treatment Outcome.
- MESH :
- chemically induced : Osteoporosis.
- complications : Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions, Neoplasms, Second Primary, Radiation Injuries, Thromboembolism.
- etiology : Lymphedema.
- therapy : Breast Neoplasms.
- Disease-Free Survival, Female, Humans, Life Style, Patient Compliance, Quality of Life, Treatment Outcome.
Abstract
As breast cancer becomes a chronic condition rather than a life-threatening illness, survivors not only have the challenge of dealing with multiple long-term side effects of treatment protocols, but may also be forced to address the preexisting comorbidities of their therapies, which often include multiple other issues. It is imperative that the information available regarding survivorship issues be accessible in an organized and useful format. This article is a modest attempt to provide a comprehensive review of the long-term medical issues.
DOI: 10.7812/TPP/14-241
PubMed: 25902343
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000F28
Links to Exploration step
pubmed:25902343Curation
No country items
Phillip Tuso<affiliation><nlm:affiliation>Nephrologist at the Antelope Valley Medical Center in CA. phillip.j.tuso@kp.org.</nlm:affiliation>
<wicri:noCountry code="no comma">Nephrologist at the Antelope Valley Medical Center in CA. phillip.j.tuso@kp.org.</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.</title>
<author><name sortKey="Bodai, Balazs I" sort="Bodai, Balazs I" uniqKey="Bodai B" first="Balazs I" last="Bodai">Balazs I. Bodai</name>
<affiliation wicri:level="2"><nlm:affiliation>Director of The Breast Cancer Survivorship Institute in Sacramento, CA. balazs.bodai@kp.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Director of The Breast Cancer Survivorship Institute in Sacramento</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Tuso, Phillip" sort="Tuso, Phillip" uniqKey="Tuso P" first="Phillip" last="Tuso">Phillip Tuso</name>
<affiliation><nlm:affiliation>Nephrologist at the Antelope Valley Medical Center in CA. phillip.j.tuso@kp.org.</nlm:affiliation>
<wicri:noCountry code="no comma">Nephrologist at the Antelope Valley Medical Center in CA. phillip.j.tuso@kp.org.</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25902343</idno>
<idno type="pmid">25902343</idno>
<idno type="doi">10.7812/TPP/14-241</idno>
<idno type="wicri:Area/PubMed/Corpus">000F28</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F28</idno>
<idno type="wicri:Area/PubMed/Curation">000F28</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F28</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.</title>
<author><name sortKey="Bodai, Balazs I" sort="Bodai, Balazs I" uniqKey="Bodai B" first="Balazs I" last="Bodai">Balazs I. Bodai</name>
<affiliation wicri:level="2"><nlm:affiliation>Director of The Breast Cancer Survivorship Institute in Sacramento, CA. balazs.bodai@kp.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Director of The Breast Cancer Survivorship Institute in Sacramento</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Tuso, Phillip" sort="Tuso, Phillip" uniqKey="Tuso P" first="Phillip" last="Tuso">Phillip Tuso</name>
<affiliation><nlm:affiliation>Nephrologist at the Antelope Valley Medical Center in CA. phillip.j.tuso@kp.org.</nlm:affiliation>
<wicri:noCountry code="no comma">Nephrologist at the Antelope Valley Medical Center in CA. phillip.j.tuso@kp.org.</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j">The Permanente journal</title>
<idno type="eISSN">1552-5775</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (complications)</term>
<term>Breast Neoplasms (therapy)</term>
<term>Disease-Free Survival</term>
<term>Drug-Related Side Effects and Adverse Reactions (complications)</term>
<term>Female</term>
<term>Humans</term>
<term>Life Style</term>
<term>Lymphedema (etiology)</term>
<term>Neoplasms, Second Primary (complications)</term>
<term>Osteoporosis (chemically induced)</term>
<term>Patient Compliance</term>
<term>Quality of Life</term>
<term>Radiation Injuries (complications)</term>
<term>Thromboembolism (complications)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Effets secondaires indésirables des médicaments ()</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème (étiologie)</term>
<term>Lésions radio-induites ()</term>
<term>Mode de vie</term>
<term>Observance thérapeutique</term>
<term>Ostéoporose ()</term>
<term>Qualité de vie</term>
<term>Résultat thérapeutique</term>
<term>Seconde tumeur primitive ()</term>
<term>Survie sans rechute</term>
<term>Thromboembolie ()</term>
<term>Tumeurs du sein ()</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Osteoporosis</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term>
<term>Drug-Related Side Effects and Adverse Reactions</term>
<term>Neoplasms, Second Primary</term>
<term>Radiation Injuries</term>
<term>Thromboembolism</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease-Free Survival</term>
<term>Female</term>
<term>Humans</term>
<term>Life Style</term>
<term>Patient Compliance</term>
<term>Quality of Life</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Effets secondaires indésirables des médicaments</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lésions radio-induites</term>
<term>Mode de vie</term>
<term>Observance thérapeutique</term>
<term>Ostéoporose</term>
<term>Qualité de vie</term>
<term>Résultat thérapeutique</term>
<term>Seconde tumeur primitive</term>
<term>Survie sans rechute</term>
<term>Thromboembolie</term>
<term>Tumeurs du sein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">As breast cancer becomes a chronic condition rather than a life-threatening illness, survivors not only have the challenge of dealing with multiple long-term side effects of treatment protocols, but may also be forced to address the preexisting comorbidities of their therapies, which often include multiple other issues. It is imperative that the information available regarding survivorship issues be accessible in an organized and useful format. This article is a modest attempt to provide a comprehensive review of the long-term medical issues.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25902343</PMID>
<DateCreated><Year>2015</Year>
<Month>04</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>01</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1552-5775</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>19</Volume>
<Issue>2</Issue>
<PubDate><Year>2015</Year>
<Season>Spring</Season>
</PubDate>
</JournalIssue>
<Title>The Permanente journal</Title>
<ISOAbbreviation>Perm J</ISOAbbreviation>
</Journal>
<ArticleTitle>Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.</ArticleTitle>
<Pagination><MedlinePgn>48-79</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.7812/TPP/14-241</ELocationID>
<Abstract><AbstractText>As breast cancer becomes a chronic condition rather than a life-threatening illness, survivors not only have the challenge of dealing with multiple long-term side effects of treatment protocols, but may also be forced to address the preexisting comorbidities of their therapies, which often include multiple other issues. It is imperative that the information available regarding survivorship issues be accessible in an organized and useful format. This article is a modest attempt to provide a comprehensive review of the long-term medical issues.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bodai</LastName>
<ForeName>Balazs I</ForeName>
<Initials>BI</Initials>
<AffiliationInfo><Affiliation>Director of The Breast Cancer Survivorship Institute in Sacramento, CA. balazs.bodai@kp.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tuso</LastName>
<ForeName>Phillip</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Nephrologist at the Antelope Valley Medical Center in CA. phillip.j.tuso@kp.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Perm J</MedlineTA>
<NlmUniqueID>9800474</NlmUniqueID>
<ISSNLinking>1552-5767</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Natl Compr Canc Netw. 2013 Aug;11 Suppl 3:S1-50; quiz S51</RefSource>
<PMID Version="1">23997241</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2009 Jul;10(7):638-9</RefSource>
<PMID Version="1">19573793</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Cases Miner Bone Metab. 2011 Sep;8(3):44-8</RefSource>
<PMID Version="1">22461829</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2013 Apr 9;127(14):1476-85</RefSource>
<PMID Version="1">23569119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2776-81</RefSource>
<PMID Version="1">9874397</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 1983 Jun;71(6):1893-6</RefSource>
<PMID Version="1">6345590</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2005 Jun;16(6):899-908</RefSource>
<PMID Version="1">15821120</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2006;(4):CD005001</RefSource>
<PMID Version="1">17054230</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Nov 10;26(32):5213-9</RefSource>
<PMID Version="1">18838709</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Dec 20;25(36):5715-22</RefSource>
<PMID Version="1">17998546</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1999 May;17(5):1474-81</RefSource>
<PMID Version="1">10334533</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Patient Prefer Adherence. 2012;6:435-48</RefSource>
<PMID Version="1">22791981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Oct 15;63(20):6643-50</RefSource>
<PMID Version="1">14583457</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 1996 Sep;83(9):1258</RefSource>
<PMID Version="1">8983622</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2007;9(1):R6</RefSource>
<PMID Version="1">17239243</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mo Med. 2013 Jan-Feb;110(1):65-70</RefSource>
<PMID Version="1">23457755</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2003 Apr 20;104(4):488-95</RefSource>
<PMID Version="1">12584748</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2005 Aug;93 Suppl 1:S23-7</RefSource>
<PMID Version="1">16100522</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65</RefSource>
<PMID Version="1">12237281</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2011 Jan 25;57(4):453-4</RefSource>
<PMID Version="1">21251586</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1995 Apr 6;332(14):907-11</RefSource>
<PMID Version="1">7877647</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bone. 2001 Nov;29(5):477-86</RefSource>
<PMID Version="1">11704501</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 2006 Dec 16;333(7581):1251-6</RefSource>
<PMID Version="1">17170416</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2001 Jan 17;93(2):96-111</RefSource>
<PMID Version="1">11208879</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2012 Jan;23(1):98-104</RefSource>
<PMID Version="1">21460377</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 1998 Mar;62(3):676-89</RefSource>
<PMID Version="1">9497246</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neoplasia. 2002 Nov-Dec;4(6):465-73</RefSource>
<PMID Version="1">12407439</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2005 Feb;16(2):253-8</RefSource>
<PMID Version="1">15668279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Health Aff (Millwood). 2007 May-Jun;26(3):761-9</RefSource>
<PMID Version="1">17485755</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Oct 20;30(30):3726-33</RefSource>
<PMID Version="1">23008299</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2000 Aug 2;92(15):1260-6</RefSource>
<PMID Version="1">10922411</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Med Sci Monit. 2009 Jan;15(1):CR5-9</RefSource>
<PMID Version="1">19114969</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Feb 1;24(4):675-80</RefSource>
<PMID Version="1">16446340</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41</RefSource>
<PMID Version="1">22700443</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Obstet Gynecol. 2006 Jun;107(6):1475-8</RefSource>
<PMID Version="1">16738185</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Oncol. 2012;2012:879623</RefSource>
<PMID Version="1">21977033</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2001 Mar 1;19(5):1455-61</RefSource>
<PMID Version="1">11230491</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mayo Clin Proc. 2008 Jun;83(6):679-86</RefSource>
<PMID Version="1">18533085</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2010 Dec;11(12):1135-41</RefSource>
<PMID Version="1">21087898</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):409-17</RefSource>
<PMID Version="1">21288654</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2009 Sep;1173 Suppl 1:E64-7</RefSource>
<PMID Version="1">19751417</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 2002 Nov 15;100(10):3484-8</RefSource>
<PMID Version="1">12393647</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2003 Jan 21;138(2):90-7</RefSource>
<PMID Version="1">12529090</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2011 Sep 7;103(17):1299-309</RefSource>
<PMID Version="1">21743022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 1992 Sep;75(3):779-82</RefSource>
<PMID Version="1">1517366</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Endocrinol. 2013;2013:632461</RefSource>
<PMID Version="1">23983688</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Indian J Endocrinol Metab. 2011 Jul;15(Suppl 2):S107-12</RefSource>
<PMID Version="1">21966645</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2009;11(5):106</RefSource>
<PMID Version="1">19735584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2003 Aug 15;98(4):697-702</RefSource>
<PMID Version="1">12910512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Natl Health Stat Report. 2010 Nov 3;(27):1-32</RefSource>
<PMID Version="1">21089986</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Oct 20;353(16):1659-72</RefSource>
<PMID Version="1">16236737</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Plast Surg. 2007 Oct;59(4):464-72</RefSource>
<PMID Version="1">17901744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Oct 1;92(7):1783-7</RefSource>
<PMID Version="1">11745250</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 2012 Apr 9;172(7):555-63</RefSource>
<PMID Version="1">22412075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bone. 2009 Aug;45(2):174-9</RefSource>
<PMID Version="1">19446053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2003 Apr 1;21(7):1195-204</RefSource>
<PMID Version="1">12663705</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast. 2010 Dec;19(6):506-15</RefSource>
<PMID Version="1">20561790</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 2004 Jan;187(1):69-72</RefSource>
<PMID Version="1">14706589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2006 Jun 21;295(23):2727-41</RefSource>
<PMID Version="1">16754727</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2002 Feb 1;20(3):719-26</RefSource>
<PMID Version="1">11821453</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2005 Dec 17;366(9503):2087-106</RefSource>
<PMID Version="1">16360786</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast. 2007 Apr;16(2):120-9</RefSource>
<PMID Version="1">17403449</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Osteoporos Int. 2009 Aug;20(8):1401-6</RefSource>
<PMID Version="1">19083073</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2006 Jan 1;106(1):35-41</RefSource>
<PMID Version="1">16333848</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Bone Miner Res. 2000 Jun;15(6):993-1000</RefSource>
<PMID Version="1">10841167</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast J. 2006 Nov-Dec;12(6):536-43</RefSource>
<PMID Version="1">17238983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):406-14</RefSource>
<PMID Version="1">11872286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2010;10:337</RefSource>
<PMID Version="1">20587042</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 Jul 20;28(21):3422-8</RefSource>
<PMID Version="1">20530280</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2007 Nov;1116:383-91</RefSource>
<PMID Version="1">18083940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes Care. 2008 Sep;31(9):1729-35</RefSource>
<PMID Version="1">18591404</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Maturitas. 1998 Nov 16;30(3):229-33</RefSource>
<PMID Version="1">9881321</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2006 Jul 12;296(2):185-92</RefSource>
<PMID Version="1">16835424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Oct 20;30(30):3655-6</RefSource>
<PMID Version="1">23008327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 1961 Aug 26;177:542-5</RefSource>
<PMID Version="1">13762005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Feb 1;30(4):380-6</RefSource>
<PMID Version="1">22203772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast J. 2010 Jan-Feb;16(1):48-54</RefSource>
<PMID Version="1">19889169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Aug 20;25(24):3657-63</RefSource>
<PMID Version="1">17485711</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2002 Jun 22;359(9324):2131-9</RefSource>
<PMID Version="1">12090977</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Geriatr Nurs. 2010 Jul-Aug;31(4):290-8</RefSource>
<PMID Version="1">20682408</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 2005 Feb;128(3):291-302</RefSource>
<PMID Version="1">15667530</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2003 Jun 17;107(23 Suppl 1):I9-16</RefSource>
<PMID Version="1">12814980</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Diabetes Complications. 2011 Jan-Feb;25(1):19-24</RefSource>
<PMID Version="1">19955005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Thromb Res. 2012 Oct;130 Suppl 1:S66-70</RefSource>
<PMID Version="1">23026668</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2008 Jan;9(1):45-53</RefSource>
<PMID Version="1">18083636</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Jul 20;26(21):3536-42</RefSource>
<PMID Version="1">18640935</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2010 Nov 15;116(22):5138-49</RefSource>
<PMID Version="1">20665892</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2004 Jun 15;22(12):2328-35</RefSource>
<PMID Version="1">15197194</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gen Hosp Psychiatry. 2009 Sep-Oct;31(5):436-41</RefSource>
<PMID Version="1">19703637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2002 Sep 18;94(18):1365-72</RefSource>
<PMID Version="1">12237282</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Osteoporos Int. 2005 Jul;16(7):737-42</RefSource>
<PMID Version="1">15455194</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Compr Canc Netw. 2013 Nov;11(11):1431-8</RefSource>
<PMID Version="1">24225974</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2013 Apr 17;105(8):515-25</RefSource>
<PMID Version="1">23449445</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2006 Apr;13(4):491-500</RefSource>
<PMID Version="1">16514477</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Drugs. 1998 Dec;56(6):1125-40</RefSource>
<PMID Version="1">9878997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Radiol. 2011 Aug;84(1004):743-6</RefSource>
<PMID Version="1">21159806</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2002 Jan;3(1):27-34</RefSource>
<PMID Version="1">11908507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1996 Jun 19;88(12):832-4</RefSource>
<PMID Version="1">8637050</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1994 Jun;12(6):1266-71</RefSource>
<PMID Version="1">8201388</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer. 2005;12(2):104-11</RefSource>
<PMID Version="1">15858440</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2008 Aug;124(1):31-42</RefSource>
<PMID Version="1">18575892</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2007 Nov 27;50(22):2128-32</RefSource>
<PMID Version="1">18036449</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):675-80</RefSource>
<PMID Version="1">20160274</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1998 Feb;16(2):441-52</RefSource>
<PMID Version="1">9469327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1996 Jan;14(1):78-84</RefSource>
<PMID Version="1">8558225</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Calcif Tissue Int. 2009 Jan;84(1):13-9</RefSource>
<PMID Version="1">19023510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2012 Jan-Feb;62(1):30-67</RefSource>
<PMID Version="1">22237782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1101-6</RefSource>
<PMID Version="1">22245205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2003 Jun 17;107(23 Suppl 1):I17-21</RefSource>
<PMID Version="1">12814981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1441-8</RefSource>
<PMID Version="1">12433724</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Surg. 2010 Nov;145(11):1055-63</RefSource>
<PMID Version="1">21079093</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 1989 May 12;244(4905):707-12</RefSource>
<PMID Version="1">2470152</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Endocr Relat Cancer. 2009 Dec;16(4):1091-102</RefSource>
<PMID Version="1">19726539</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2008 Dec 2;99(11):1763-8</RefSource>
<PMID Version="1">18985046</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Perm J. 2014 Summer;18(3):55-9</RefSource>
<PMID Version="1">24937147</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 2007 Apr;137(1):77-8; author reply 79-80</RefSource>
<PMID Version="1">17359373</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Calcif Tissue Int. 2008 Apr;82(4):249-57</RefSource>
<PMID Version="1">18414920</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mayo Clin Proc. 2008 Feb;83(2):197-203</RefSource>
<PMID Version="1">18241629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2007 Jul;246(1):42-5</RefSource>
<PMID Version="1">17592289</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1984 Oct 1;54(7):1264-8</RefSource>
<PMID Version="1">6547874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2011 Feb;50(2):187-93</RefSource>
<PMID Version="1">21231780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2007;7:9</RefSource>
<PMID Version="1">17224064</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2003 Jul 1;105(4):568-73</RefSource>
<PMID Version="1">12712452</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Pract. 2000 Sep-Oct;8(5):231-7</RefSource>
<PMID Version="1">11898235</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Sep 1;25(25):3871-6</RefSource>
<PMID Version="1">17664457</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2000 Jul 19;92(14):1143-50</RefSource>
<PMID Version="1">10904087</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2001 May 15;103(19):2318-20</RefSource>
<PMID Version="1">11352875</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 2007 Jun 25;167(12):1231-2</RefSource>
<PMID Version="1">17592094</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Prev Res (Phila). 2012 Apr;5(4):515-21</RefSource>
<PMID Version="1">22392012</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2009 Apr;14(4):320-68</RefSource>
<PMID Version="1">19346299</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 1987 Jan 9;235(4785):177-82</RefSource>
<PMID Version="1">3798106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 2013;347:f5001</RefSource>
<PMID Version="1">23990623</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Med. 2010 Oct;123(10):877-84</RefSource>
<PMID Version="1">20920685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Cardiovasc Drugs. 2005;5(4):233-43</RefSource>
<PMID Version="1">15984906</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Jun 2;352(22):2302-13</RefSource>
<PMID Version="1">15930421</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2000 Jun;61(3):183-95</RefSource>
<PMID Version="1">10965995</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Clin Pract. 2010 May;64(6):817-20</RefSource>
<PMID Version="1">20518955</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Health Serv Res. 2002 Apr;37(2):417-31</RefSource>
<PMID Version="1">12036001</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 1994 Sep 30;734:310-21</RefSource>
<PMID Version="1">7978932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Jun 20;24(18):2765-72</RefSource>
<PMID Version="1">16702582</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1998 May 16;351(9114):1451-67</RefSource>
<PMID Version="1">9605801</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Palliat Support Care. 2008 Dec;6(4):377-87</RefSource>
<PMID Version="1">19006593</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Sex Med. 2012 Jan;9(1):5-13; quiz 14-5</RefSource>
<PMID Version="1">22151953</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Oct 20;353(16):1673-84</RefSource>
<PMID Version="1">16236738</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2009 May 1;115(9):1954-66</RefSource>
<PMID Version="1">19248047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Drug Saf. 2006;29(7):567-86</RefSource>
<PMID Version="1">16808550</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2001 Mar 15;19(6):1707-15</RefSource>
<PMID Version="1">11251000</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Perm J. 2014 Spring;18(2):58-63</RefSource>
<PMID Version="1">24694316</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 2005 Mar 14;165(5):552-8</RefSource>
<PMID Version="1">15767532</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1999 Nov 15;86(10):2014-20</RefSource>
<PMID Version="1">10570426</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast. 2013 Dec;22(6):1009-18</RefSource>
<PMID Version="1">24144949</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1545-50</RefSource>
<PMID Version="1">15905465</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Psychiatry. 2009 Dec;70(12):1688-97</RefSource>
<PMID Version="1">20141708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2013 Jul 1;119(13):2375-82</RefSource>
<PMID Version="1">23575918</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2002 Feb 15;20(4):1128-43</RefSource>
<PMID Version="1">11844838</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Feb;120(1):127-34</RefSource>
<PMID Version="1">20035381</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Sep 1;24(25):4056-8</RefSource>
<PMID Version="1">16908930</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2011;11:384</RefSource>
<PMID Version="1">21875433</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2012 Oct;23(10):1721-8</RefSource>
<PMID Version="1">22918549</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Gen Pract. 1993 Mar;43(368):107-9</RefSource>
<PMID Version="1">8323787</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1995 Jul;13(7):1557-63</RefSource>
<PMID Version="1">7602344</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2009 Jan;18(1):14-22</RefSource>
<PMID Version="1">18457335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2007 Mar 1;109(5):966-74</RefSource>
<PMID Version="1">17243096</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2012 Sep 5;104(17):1293-305</RefSource>
<PMID Version="1">22949432</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2011 Feb;12(2):160-74</RefSource>
<PMID Version="1">21251875</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Compr Canc Netw. 2013 Oct 1;11(10):1298-302</RefSource>
<PMID Version="1">24142829</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2013 Sep;24(9):2206-23</RefSource>
<PMID Version="1">23917950</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Osteoporos Int. 2005 Feb;16(2):155-62</RefSource>
<PMID Version="1">15175845</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Vasc Med. 1997 Nov;2(4):321-6</RefSource>
<PMID Version="1">9575606</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2013 Mar 1;31(7):961-5</RefSource>
<PMID Version="1">23129741</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Aug 1;23(22):5166-70</RefSource>
<PMID Version="1">16051958</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 Mar 20;28(9):1473-80</RefSource>
<PMID Version="1">20177030</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2011 Nov 12;378(9804):1707-16</RefSource>
<PMID Version="1">22019144</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2004 Nov 3;96(21):1577-84</RefSource>
<PMID Version="1">15523086</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Calcif Tissue Int. 2006 Aug;79(2):76-83</RefSource>
<PMID Version="1">16927047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Health Aff (Millwood). 2011 Aug;30(8):1434-42</RefSource>
<PMID Version="1">21821561</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2004 Aug 31;91(5):868-72</RefSource>
<PMID Version="1">15292931</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Mammary Gland Biol Neoplasia. 2004 Jul;9(3):221-36</RefSource>
<PMID Version="1">15557796</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2013 Jul;140(2):233-40</RefSource>
<PMID Version="1">23860926</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2003 Nov 15;21(22):4222-7</RefSource>
<PMID Version="1">14615451</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Recent Results Cancer Res. 2011;186:13-42</RefSource>
<PMID Version="1">21113759</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Aug;134(3):915-22</RefSource>
<PMID Version="1">22415476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2009 Sep;20(9):1489-98</RefSource>
<PMID Version="1">19474112</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am Surg. 2004 Oct;70(10):881-5</RefSource>
<PMID Version="1">15529842</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):287-301</RefSource>
<PMID Version="1">11319168</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Drugs. 2006;66(2):191-221</RefSource>
<PMID Version="1">16451093</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):656-65</RefSource>
<PMID Version="1">20159360</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2012 Apr 15;118(8 Suppl):2277-87</RefSource>
<PMID Version="1">22488702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Crit Rev Oncol Hematol. 2005 Apr;54(1):11-29</RefSource>
<PMID Version="1">15780905</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Value Health. 2008 Jan-Feb;11(1):44-7</RefSource>
<PMID Version="1">18237359</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gen Hosp Psychiatry. 2008 Mar-Apr;30(2):112-26</RefSource>
<PMID Version="1">18291293</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2008 Jul 5;372(9632):40-8</RefSource>
<PMID Version="1">18603157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Med Res. 2010 Dec;8(3-4):168-72</RefSource>
<PMID Version="1">20739582</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):997-1002</RefSource>
<PMID Version="1">19251087</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2003;42(5-6):532-45</RefSource>
<PMID Version="1">14596511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 1996 Jul 1;125(1):1-7</RefSource>
<PMID Version="1">8644983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1991 Nov 15;51(22):6094-7</RefSource>
<PMID Version="1">1933872</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2013 Jun 15;381(9883):2077-8</RefSource>
<PMID Version="1">23769223</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2010 Apr;49(3):305-12</RefSource>
<PMID Version="1">20156115</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2003 May;79(2):143-7</RefSource>
<PMID Version="1">12825849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 2009 Aug 10;169(15):1355-62</RefSource>
<PMID Version="1">19667296</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer. 2011 Jul;18(3):174-80</RefSource>
<PMID Version="1">21331463</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Jan;131(2):371-83</RefSource>
<PMID Version="1">21956210</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Bone Miner Res. 1994 Aug;9(8):1137-41</RefSource>
<PMID Version="1">7976495</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Aug 4;353(5):487-97</RefSource>
<PMID Version="1">16079372</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1998 Nov 26;339(22):1609-18</RefSource>
<PMID Version="1">9828250</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Aug 10;25(23):3525-33</RefSource>
<PMID Version="1">17687157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2008 Aug 20;100(16):1179-83</RefSource>
<PMID Version="1">18695137</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Cardiol. 2014 Jan 15;113(2):410-1</RefSource>
<PMID Version="1">24210676</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Osteoporos Int. 2005 Jun;16(6):581-9</RefSource>
<PMID Version="1">15616758</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2003 Jan;14(1):71-3</RefSource>
<PMID Version="1">12488295</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Hum Hypertens. 2007 Sep;21(9):717-28</RefSource>
<PMID Version="1">17443205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Fam Cancer. 2007;6(4):453-61</RefSource>
<PMID Version="1">17624602</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Annu Rev Nutr. 2001;21:381-406</RefSource>
<PMID Version="1">11375442</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2013 Jan 1;127(1):e6-e245</RefSource>
<PMID Version="1">23239837</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2014 Apr;21(4):1202-8</RefSource>
<PMID Version="1">24337542</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2013;13:407</RefSource>
<PMID Version="1">24006873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 1989 May 12;261(18):2653-5</RefSource>
<PMID Version="1">2709545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Surg. 1996 May;131(5):472-80</RefSource>
<PMID Version="1">8624191</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Perm J. 2014 Summer;18(3):88-93</RefSource>
<PMID Version="1">25102521</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2013 May;20(5):1514-21</RefSource>
<PMID Version="1">23224829</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pharmacoepidemiol Drug Saf. 2004 May;13(5):289-94</RefSource>
<PMID Version="1">15133779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2814-6</RefSource>
<PMID Version="1">9874403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes Care. 2004 May;27(5):1047-53</RefSource>
<PMID Version="1">15111519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2005 Dec;115(12):3318-25</RefSource>
<PMID Version="1">16322775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hematol Oncol Clin North Am. 1996 Apr;10(2):499-530</RefSource>
<PMID Version="1">8707766</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Perm J. 2014 Fall;18(4):52-7</RefSource>
<PMID Version="1">25662527</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2010 Jan;37(1):E28-33</RefSource>
<PMID Version="1">20044329</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1996 Nov;14(11):3009-17</RefSource>
<PMID Version="1">8918499</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1992 Apr 23;326(17):1102-7</RefSource>
<PMID Version="1">1552911</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Apr 10;25(11):1329-33</RefSource>
<PMID Version="1">17416853</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2002 Oct 17;347(16):1233-41</RefSource>
<PMID Version="1">12393820</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 1996 Feb;2(2):209-15</RefSource>
<PMID Version="1">8574967</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2007 Mar 1;109(5):832-9</RefSource>
<PMID Version="1">17243168</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2005 Jan 1-7;365(9453):60-2</RefSource>
<PMID Version="1">15639680</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Mar 10;26(8):1239-46</RefSource>
<PMID Version="1">18323547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 2007 Jun 25;167(12):1240-5</RefSource>
<PMID Version="1">17592096</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2000 May 2;132(9):743-56</RefSource>
<PMID Version="1">10787370</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Aug 20;26(24):3958-64</RefSource>
<PMID Version="1">18711185</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1994 Apr 6;86(7):527-37</RefSource>
<PMID Version="1">8133536</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):316-20</RefSource>
<PMID Version="1">19228604</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Dec 1;23(34):8597-605</RefSource>
<PMID Version="1">16314622</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2007 Dec;106(3):439-51</RefSource>
<PMID Version="1">17277968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1209-15</RefSource>
<PMID Version="1">12654429</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bone. 2012 Sep;51(3):606-13</RefSource>
<PMID Version="1">22659406</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Gastroenterol. 2012 Sep;107(9):1361-9</RefSource>
<PMID Version="1">22777336</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Altern Ther Health Med. 2009 Nov-Dec;15(6):12-4</RefSource>
<PMID Version="1">19943572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Opin Rheumatol. 2005 Jul;17(4):475-9</RefSource>
<PMID Version="1">15956846</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes Metab. 2008 Jun;34(3):193-205</RefSource>
<PMID Version="1">18308607</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Toxicol Appl Pharmacol. 2007 Nov 1;224(3):274-83</RefSource>
<PMID Version="1">17306316</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2010 Dec;11(12):1184-92</RefSource>
<PMID Version="1">20541465</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1484-95</RefSource>
<PMID Version="1">18035211</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes Care. 2005 Sep;28(9):2130-5</RefSource>
<PMID Version="1">16123478</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2003 Dec 15;21(24):4524-31</RefSource>
<PMID Version="1">14673039</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pain Symptom Manage. 1992 Feb;7(2):110-6</RefSource>
<PMID Version="1">1573284</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S77-85</RefSource>
<PMID Version="1">20171522</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2007 Nov 15;110(10):2339-46</RefSource>
<PMID Version="1">17918266</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2006 Mar 22;295(12):1379-88</RefSource>
<PMID Version="1">16551709</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Gen Intern Med. 2003 Nov;18(11):937-47</RefSource>
<PMID Version="1">14687281</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2000 Dec 21;343(25):1846-50</RefSource>
<PMID Version="1">11117976</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 Jan 1;28(1):92-8</RefSource>
<PMID Version="1">19933921</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2011 Feb 9;305(6):569-75</RefSource>
<PMID Version="1">21304082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst Monogr. 2004;(32):57-71</RefSource>
<PMID Version="1">15263042</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ital Heart J Suppl. 2001 Feb;2(2):125-41</RefSource>
<PMID Version="1">11255880</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Jul 1;23(19):4312-21</RefSource>
<PMID Version="1">15994144</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Jul 1;23(19):4265-74</RefSource>
<PMID Version="1">15911866</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2006 Jan 28;367(9507):320-6</RefSource>
<PMID Version="1">16443039</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Aust N Z J Surg. 2000 Jun;70(6):412-8</RefSource>
<PMID Version="1">10843395</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes Care. 2009 May;32(5):791-6</RefSource>
<PMID Version="1">19351712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):775-82</RefSource>
<PMID Version="1">17416770</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast. 2014 Aug;23(4):393-9</RefSource>
<PMID Version="1">24675394</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2003 Jun;14(6):833-42</RefSource>
<PMID Version="1">12796019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2004 May 15;22(10):1830-8</RefSource>
<PMID Version="1">15143075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1989 Jul 19;81(14):1086-8</RefSource>
<PMID Version="1">2738937</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Oncol Pract. 2005 Nov;1(4):155-9</RefSource>
<PMID Version="1">20871698</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1020-4</RefSource>
<PMID Version="1">18029105</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Compr Canc Netw. 2008 Mar;6 Suppl 3:S1-14</RefSource>
<PMID Version="1">18377852</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Annu Rev Med. 2006;57:485-98</RefSource>
<PMID Version="1">16409162</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br Heart J. 1973 Jun;35(6):623-5</RefSource>
<PMID Version="1">4123229</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>NCI Monogr. 1986;(1):119-23</RefSource>
<PMID Version="1">3534584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533-7</RefSource>
<PMID Version="1">3487091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Oct 20;30(30):3657-64</RefSource>
<PMID Version="1">23008297</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Jul;134(2):459-78</RefSource>
<PMID Version="1">22689091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Med Res. 2006 May;37(4):511-6</RefSource>
<PMID Version="1">16624651</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Osteoporos Int. 2007 Oct;18(10):1319-28</RefSource>
<PMID Version="1">17566815</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Jan;113(2):383-91</RefSource>
<PMID Version="1">18297429</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Compr Canc Netw. 2014 Mar 1;12(3):365-73</RefSource>
<PMID Version="1">24616542</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 Sep 20;28(27):4120-8</RefSource>
<PMID Version="1">20585090</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2011 Jun;37(4):300-11</RefSource>
<PMID Version="1">21126826</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Clin Nutr. 2000 May;71(5):1062-76</RefSource>
<PMID Version="1">10799367</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Sci (Lond). 2007 Sep;113(5):233-41</RefSource>
<PMID Version="1">17663660</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Bone Miner Res. 2004 Sep;19(9):1420-31</RefSource>
<PMID Version="1">15312242</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Bone Miner Metab. 2009;27(5):598-604</RefSource>
<PMID Version="1">19373518</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1998 Sep 19;352(9132):930-42</RefSource>
<PMID Version="1">9752815</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Endocrinol. 2013;2013:638727</RefSource>
<PMID Version="1">23970897</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2005 May;16(5):696-701</RefSource>
<PMID Version="1">15802275</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Oct 20;30(30):3665-74</RefSource>
<PMID Version="1">23008309</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2012 Jun;23(6):1394-402</RefSource>
<PMID Version="1">22234738</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Endocr Pract. 2007 May-Jun;13 Suppl 1:1-68</RefSource>
<PMID Version="1">17613449</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2010 Sep;43(3):118-27</RefSource>
<PMID Version="1">21226414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Psychiatry. 2008 Oct;165(10):1251-5</RefSource>
<PMID Version="1">18829880</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2007 Jul;12(7):756-65</RefSource>
<PMID Version="1">17673607</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Rheumatol Rep. 2010 Jun;12(3):186-91</RefSource>
<PMID Version="1">20425518</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>World J Diabetes. 2011 Mar 15;2(3):41-8</RefSource>
<PMID Version="1">21537459</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabet Med. 2009 Jan;26(1):45-52</RefSource>
<PMID Version="1">19125760</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2010 Jan 6;102(1):14-25</RefSource>
<PMID Version="1">20007921</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2004 Nov 1;22(21):4261-71</RefSource>
<PMID Version="1">15514369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Strahlenther Onkol. 2008 Jul;184(7):347-53</RefSource>
<PMID Version="1">19016032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2002;41(4):323-33</RefSource>
<PMID Version="1">12234023</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncologist. 1999;4(6):443-9</RefSource>
<PMID Version="1">10631688</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2002 Oct 17;347(16):1227-32</RefSource>
<PMID Version="1">12393819</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2001 Mar 1;19(5):1539-69</RefSource>
<PMID Version="1">11230499</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Drug Saf. 2006;29(9):785-801</RefSource>
<PMID Version="1">16944964</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2009 Oct;16(10):2669-72</RefSource>
<PMID Version="1">19644723</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1994 Nov 5;344(8932):1244</RefSource>
<PMID Version="1">7967983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Oct 20;30(30):3734-45</RefSource>
<PMID Version="1">23008293</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 1996 Apr;32A(4):576-88</RefSource>
<PMID Version="1">8695256</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 1981 May;141(6):758-63</RefSource>
<PMID Version="1">7235784</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2005 Sep 7;97(17):1262-71</RefSource>
<PMID Version="1">16145047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 1992 Jan 1;116(1):26-32</RefSource>
<PMID Version="1">1727092</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2013 Jun;24(6):1505-12</RefSource>
<PMID Version="1">23378537</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast. 2002 Feb;11(1):66-71</RefSource>
<PMID Version="1">14965648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2007 Jun;18 Suppl 6:vi26-30</RefSource>
<PMID Version="1">17591827</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Semin Oncol. 1998 Aug;25(4 Suppl 10):72-85</RefSource>
<PMID Version="1">9768828</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2001 Feb 15;19(4):943-53</RefSource>
<PMID Version="1">11181656</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Crit Rev Oncol Hematol. 2010 Dec;76(3):186-95</RefSource>
<PMID Version="1">20138541</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Psychopharmacol. 2004 Dec;24(6):632-8</RefSource>
<PMID Version="1">15538126</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Clin Nutr. 2005 Jan;81(1 Suppl):292S-297S</RefSource>
<PMID Version="1">15640493</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2005 May 25;293(20):2479-86</RefSource>
<PMID Version="1">15914748</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Oct 20;30(30):3687-96</RefSource>
<PMID Version="1">23008320</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Feb 10;25(5):486-92</RefSource>
<PMID Version="1">17200148</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Feb 1;26(4):556-62</RefSource>
<PMID Version="1">18180462</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Clin Oncol. 2012 Sep;9(9):498-509</RefSource>
<PMID Version="1">22850752</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2013 Mar 9;381(9869):805-16</RefSource>
<PMID Version="1">23219286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 2009;339:b3999</RefSource>
<PMID Version="1">19833707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Mar 20;30(9):936-42</RefSource>
<PMID Version="1">22331951</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2006 Dec 20;98(24):1767-76</RefSource>
<PMID Version="1">17179478</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bone. 2006 Aug;39(2):253-9</RefSource>
<PMID Version="1">16574519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):694-701</RefSource>
<PMID Version="1">23628135</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Endocr Rev. 2008 Feb;29(1):76-131</RefSource>
<PMID Version="1">17991805</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1996 Oct;14(10):2722-30</RefSource>
<PMID Version="1">8874333</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Osteoporos Int. 2005 Jul;16(7):713-6</RefSource>
<PMID Version="1">15776217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2004 Jun 29;109(25):3122-31</RefSource>
<PMID Version="1">15226229</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Bone Miner Res. 2010 Feb;25(2):285-91</RefSource>
<PMID Version="1">19594301</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2007 Feb 7;99(3):196-205</RefSource>
<PMID Version="1">17284714</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2009 May 1;115(9):1813-26</RefSource>
<PMID Version="1">19235248</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Nutr. 2006 Jun;136(6):1453-6</RefSource>
<PMID Version="1">16702302</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2010 Jan;28(1):54-62</RefSource>
<PMID Version="1">19916749</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2010 Jan;28(1):44-5</RefSource>
<PMID Version="1">20001296</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2011 Jan 19;103(2):117-28</RefSource>
<PMID Version="1">21228314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2008 Dec;13(12):1224-34</RefSource>
<PMID Version="1">19091778</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Med Assoc. 2007 Nov;99(11):1227-8, 1231-4</RefSource>
<PMID Version="1">18020097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Prev Med. 2012 Jul;55(1):23-7</RefSource>
<PMID Version="1">22564893</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Clin Nutr. 2005 May;81(5):1232S-1239S</RefSource>
<PMID Version="1">15883457</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2005 Mar 2;97(5):375-84</RefSource>
<PMID Version="1">15741574</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Drug Saf. 2000 Apr;22(4):263-302</RefSource>
<PMID Version="1">10789823</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2008 Jan 1;14(1):14-24</RefSource>
<PMID Version="1">18172247</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Prev Res (Phila). 2011 Sep;4(9):1409-18</RefSource>
<PMID Version="1">21795422</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2004;43(6):551-7</RefSource>
<PMID Version="1">15370612</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2001 Mar 15;344(11):783-92</RefSource>
<PMID Version="1">11248153</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Dermatol. 2001 Dec;145(6):981-5</RefSource>
<PMID Version="1">11899153</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Sep 15;92(6):1368-77</RefSource>
<PMID Version="1">11745212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Coll Surg. 2008 Jan;206(1):66-75</RefSource>
<PMID Version="1">18155570</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 1986 Nov;68(5):1114-8</RefSource>
<PMID Version="1">3533179</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2004 Jan 26;90(2):314-20</RefSource>
<PMID Version="1">14735170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1982 Jun 1;49(11):2295-9</RefSource>
<PMID Version="1">7074546</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2009 Mar;20(3):401-2</RefSource>
<PMID Version="1">19246419</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Oct 20;30(30):3712-9</RefSource>
<PMID Version="1">23008322</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Bone Miner Res. 2005 Jul;20(7):1185-94</RefSource>
<PMID Version="1">15940371</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2003 Apr 15;21(8):1431-9</RefSource>
<PMID Version="1">12668651</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1992 Mar 26;326(13):852-6</RefSource>
<PMID Version="1">1542321</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2013 Apr 16;108(7):1515-24</RefSource>
<PMID Version="1">23519057</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Jun 10;25(17):2345-51</RefSource>
<PMID Version="1">17557947</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cardiol Res Pract. 2011 Mar 03;2011:394740</RefSource>
<PMID Version="1">21403876</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Jul;110(1):9-17</RefSource>
<PMID Version="1">17674188</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>QJM. 2005 May;98(5):343-8</RefSource>
<PMID Version="1">15820971</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 2005 May 23;165(10):1173-8</RefSource>
<PMID Version="1">15911732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast. 2003 Dec;12(6):472-4</RefSource>
<PMID Version="1">14659123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2012 Jul 3;126(1):126-32</RefSource>
<PMID Version="1">22753534</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2002 Nov;8(11):3360-8</RefSource>
<PMID Version="1">12429622</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 2003 Feb 1;326(7383):256-7</RefSource>
<PMID Version="1">12560277</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1991 Jul 13;338(8759):82-3</RefSource>
<PMID Version="1">1676470</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2000 May 20;355(9217):1757-70</RefSource>
<PMID Version="1">10832826</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Sep 1;24(25):4059-61</RefSource>
<PMID Version="1">16908929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Mar 10;23(8):1644-55</RefSource>
<PMID Version="1">15755972</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1997 Apr 17;336(16):1117-24</RefSource>
<PMID Version="1">9099655</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Public Health. 2013 Apr;103(4):641-8</RefSource>
<PMID Version="1">23409916</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2007 Feb;8(2):119-27</RefSource>
<PMID Version="1">17267326</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 2006 Sep;91(9):3404-10</RefSource>
<PMID Version="1">16804043</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2010 May;21 Suppl 5:v277-82</RefSource>
<PMID Version="1">20555097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88</RefSource>
<PMID Version="1">9747868</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Dec 1;27(34):e239; author reply e240-1</RefSource>
<PMID Version="1">19884526</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Med. 2008 May;121(5):406-18</RefSource>
<PMID Version="1">18456037</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2004 Dec;37(4):206-8</RefSource>
<PMID Version="1">15693539</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2014 Oct;25(10):1901-14</RefSource>
<PMID Version="1">24769692</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Clin Pract. 2007 Dec;61(12):2051-63</RefSource>
<PMID Version="1">17892469</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2003 Sep;22(3):183-98</RefSource>
<PMID Version="1">12938083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Maturitas. 2010 May;66(1):5-15</RefSource>
<PMID Version="1">20097494</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Dis. 2006-2007;27:21-50</RefSource>
<PMID Version="1">17917139</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2005 Aug;6(8):557-65</RefSource>
<PMID Version="1">16054566</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2004 Sep 20;111(5):792-4</RefSource>
<PMID Version="1">15252852</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 Jul 20;28(21):3416-21</RefSource>
<PMID Version="1">20530275</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2011 Aug;100(2):241-6</RefSource>
<PMID Version="1">21316783</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2012 Mar;135:277-86</RefSource>
<PMID Version="1">22561612</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2007 Aug;104(2):145-52</RefSource>
<PMID Version="1">17058023</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Inflamm Res. 2009 Sep;58(9):537-52</RefSource>
<PMID Version="1">19381780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Sep 1;25(25):3991-4008</RefSource>
<PMID Version="1">17577017</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2011 Sep;22(9):1939-47</RefSource>
<PMID Version="1">21289366</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oxid Med Cell Longev. 2009 Nov-Dec;2(5):270-8</RefSource>
<PMID Version="1">20716914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27</RefSource>
<PMID Version="1">16204691</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2006 May 1;118(9):2285-92</RefSource>
<PMID Version="1">16342146</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2004 Jun;37(2):73-91</RefSource>
<PMID Version="1">15328760</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 1998;37(7-8):661-4</RefSource>
<PMID Version="1">10050983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Coll Nutr. 2014;33(3):239-46</RefSource>
<PMID Version="1">24870117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Oct 27;353(17):1784-92</RefSource>
<PMID Version="1">16251534</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Jan 1;25(1):70-6</RefSource>
<PMID Version="1">17194906</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2014 Jul 20;32(21):2255-69</RefSource>
<PMID Version="1">24868023</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Clin Nutr. 2013 Aug;98(2):454-9</RefSource>
<PMID Version="1">23803880</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Med Pediatr Oncol. 1981;9(5):417-22</RefSource>
<PMID Version="1">7300803</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2004 Jan 15;22(2):322-9</RefSource>
<PMID Version="1">14722042</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2006 Jan 4;98(1):15-25</RefSource>
<PMID Version="1">16391368</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Jun 20;23(18):4179-91</RefSource>
<PMID Version="1">15961765</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2007 Sep 8;370(9590):851-8</RefSource>
<PMID Version="1">17826170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2002 Aug 1;20(15):3276-81</RefSource>
<PMID Version="1">12149302</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 1990 Dec 21;250(4988):1684-9</RefSource>
<PMID Version="1">2270482</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 Jan 1;28(1):77-82</RefSource>
<PMID Version="1">19901117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Apr 20;27(12):2007-14</RefSource>
<PMID Version="1">19289624</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1131-8</RefSource>
<PMID Version="1">17606332</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1992 May 7;326(19):1240-5</RefSource>
<PMID Version="1">1560799</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2009 May 13;301(18):1883-91</RefSource>
<PMID Version="1">19436015</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Obstet Gynecol. 2006 Feb;194(2 Suppl):S3-11</RefSource>
<PMID Version="1">16448873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 2005 Oct 1;92(1):23-31</RefSource>
<PMID Version="1">16180231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Endocr Pract. 2008 Mar;14(2):162-7</RefSource>
<PMID Version="1">18308653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Annu Rev Med. 2011;62:233-47</RefSource>
<PMID Version="1">20887199</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):501-7</RefSource>
<PMID Version="1">18374500</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):94-104</RefSource>
<PMID Version="1">20728696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Osteoporos Int. 2004 Apr;15(4):323-8</RefSource>
<PMID Version="1">14762652</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Med Chem. 2013;20(5):596-604</RefSource>
<PMID Version="1">23278394</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2005 May 14-20;365(9472):1687-717</RefSource>
<PMID Version="1">15894097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2734-46</RefSource>
<PMID Version="1">20978176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89</RefSource>
<PMID Version="1">17392385</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer Prev. 2008 Oct;17(5):406-13</RefSource>
<PMID Version="1">18714181</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1992 Jul 4;340(8810):9-13</RefSource>
<PMID Version="1">1351654</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Nov;124(1):153-61</RefSource>
<PMID Version="1">20730486</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2003 Nov 1;21(21):4042-57</RefSource>
<PMID Version="1">12963702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Prev Cardiol. 2004 Spring;7(2):73-9</RefSource>
<PMID Version="1">15133375</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Surg Oncol. 2003 May;29(4):341-50</RefSource>
<PMID Version="1">12711287</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Genet Med. 2010 May;12(5):245-59</RefSource>
<PMID Version="1">20216074</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2014 Jun 21;383(9935):2127-35</RefSource>
<PMID Version="1">24656685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Haemostasis. 1994 Mar-Apr;24(2):128-31</RefSource>
<PMID Version="1">7959360</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nutr Rev. 2006 Apr;64(4):175-88</RefSource>
<PMID Version="1">16673753</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes Care. 2009 Jan;32 Suppl 1:S62-7</RefSource>
<PMID Version="1">19118289</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bone. 2006 Dec;39(6):1313-21</RefSource>
<PMID Version="1">16884969</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Oncol Pract. 2012 Nov;8(6):e149-57</RefSource>
<PMID Version="1">23598850</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bull Cancer. 1996 Dec;83(12):989-95</RefSource>
<PMID Version="1">9116379</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2003 Feb 15;21(4):602-6</RefSource>
<PMID Version="1">12586795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2014 Jul;21(7):2197-202</RefSource>
<PMID Version="1">24599413</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Oct 10;27(29):4821-6</RefSource>
<PMID Version="1">19752337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Haemostasis. 1998;28 Suppl 3:43-9</RefSource>
<PMID Version="1">10069761</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2012 Dec 1;118(23):5937-46</RefSource>
<PMID Version="1">22926690</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2003 Nov;14(11):1617-22</RefSource>
<PMID Version="1">14581268</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2007 May;7(5):332-44</RefSource>
<PMID Version="1">17457301</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood Coagul Fibrinolysis. 1992 Aug;3(4):451-60</RefSource>
<PMID Version="1">1420820</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2014 May 20;32(15):1537-9</RefSource>
<PMID Version="1">24711547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Geriatr Pharmacother. 2010 Feb;8(1):34-46</RefSource>
<PMID Version="1">20226391</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2881-8</RefSource>
<PMID Version="1">16365005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2006;6:63</RefSource>
<PMID Version="1">16539726</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Osteoporos Int. 2007 Apr;18(4):427-44</RefSource>
<PMID Version="1">17068657</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2011 Mar 1;154(5):356-64</RefSource>
<PMID Version="1">21242341</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2006 May 18;354(20):2103-11</RefSource>
<PMID Version="1">16707747</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Thromb Haemost. 1997 Jul;78(1):141-4</RefSource>
<PMID Version="1">9198144</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Lymphoedema. 2009 Apr 1;4(1):14-18</RefSource>
<PMID Version="1">20182653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Coll Nutr. 2000 Nov-Dec;19(6):715-37</RefSource>
<PMID Version="1">11194525</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Semin Thromb Hemost. 1999;25(2):147-55</RefSource>
<PMID Version="1">10357082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Jul;134(2):479-93</RefSource>
<PMID Version="1">22706630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br Med J (Clin Res Ed). 1987 Oct 31;295(6606):1141</RefSource>
<PMID Version="1">3120919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Apr 20;25(12):1468-9</RefSource>
<PMID Version="1">17360965</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Perm J. 2015 Winter;19(1):62-7</RefSource>
<PMID Version="1">25431999</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cancer Surviv. 2011 Dec;5(4):320-36</RefSource>
<PMID Version="1">22002586</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2006 Feb 23;354(8):809-20</RefSource>
<PMID Version="1">16495393</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Oct 20;353(16):1652-4</RefSource>
<PMID Version="1">16236735</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Mar 10;26(8):1231-8</RefSource>
<PMID Version="1">18250349</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2005 Sep;93(1):91-5</RefSource>
<PMID Version="1">16184464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2009 Jan;20(1):103-9</RefSource>
<PMID Version="1">18647961</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):82-93</RefSource>
<PMID Version="1">17336464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Sep 1;24(25):4100-6</RefSource>
<PMID Version="1">16908933</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Perm J. 2013 Spring;17(2):61-6</RefSource>
<PMID Version="1">23704846</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 2014;349:g4490</RefSource>
<PMID Version="1">25073782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2006 Dec 27;296(24):2947-53</RefSource>
<PMID Version="1">17190895</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2013 Mar 14;368(11):987-98</RefSource>
<PMID Version="1">23484825</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2009 Jun 16;53(24):2231-47</RefSource>
<PMID Version="1">19520246</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):379-86</RefSource>
<PMID Version="1">18250341</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2010 Jan 5;102(1):220-6</RefSource>
<PMID Version="1">19935795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):296-7</RefSource>
<PMID Version="1">19228601</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2003 May;72(5):1117-30</RefSource>
<PMID Version="1">12677558</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2004 Mar 11;350(11):1081-92</RefSource>
<PMID Version="1">15014181</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1994 Mar 19;343(8899):692-5</RefSource>
<PMID Version="1">7907678</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2001 Jul 4;93(13):979-89</RefSource>
<PMID Version="1">11438563</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008019" MajorTopicYN="N">Life Style</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016609" MajorTopicYN="N">Neoplasms, Second Primary</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010024" MajorTopicYN="N">Osteoporosis</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011832" MajorTopicYN="N">Radiation Injuries</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013923" MajorTopicYN="N">Thromboembolism</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4403581</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>4</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>4</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>1</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25902343</ArticleId>
<ArticleId IdType="pii">14-241</ArticleId>
<ArticleId IdType="doi">10.7812/TPP/14-241</ArticleId>
<ArticleId IdType="pmc">PMC4403581</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F28 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000F28 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:25902343 |texte= Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25902343" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |